课题基金 / 基金详情

Understanding inevitable relapse of multiple myeloma following highly-effective anti-BCMA treatment

Understanding inevitable relapse of multiple myeloma following highly-effective anti-BCMA treatment
了解高效抗 BCMA 治疗后多发性骨髓瘤不可避免的复发
批准号:
434743
负责人:
Pugh Trevor J
金额:
$72.17万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
已结题
起止时间:
2020-10-01 至 2024-10-01

项目摘要

项目成果

Pugh Trevor J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple myeloma, a cancer of the bone marrow, remains difficult to treat due to the presence of numerous cancer cell subpopulations that can be resistant to treatment. We have also found that while many immune cells within the bone marrow actively combat
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 2
  • 批准号:
    471101
  • 项目类别:
  • 资助金额:
    $36.43万
  • 财政年份:
    2022
  • 负责人:
    Pugh Trevor J
  • 依托单位:
Early cancer detection in children and adults with familial cancer syndromes across Canada
  • 批准号:
    477182
  • 项目类别:
    Operating Grants
  • 资助金额:
    $135.5万
  • 财政年份:
    2022
  • 负责人:
    Pugh Trevor J
  • 依托单位:
Molecular evolution of myeloma from precursor through to relapsed disease
  • 批准号:
    382711
  • 项目类别:
    Operating Grants
  • 资助金额:
    $28.42万
  • 财政年份:
    2018
  • 负责人:
    Pugh Trevor J
  • 依托单位:
Early detection of cancer in high-risk patients through profiling of circulating tumour DNA
  • 批准号:
    382384
  • 项目类别:
    Operating Grants
  • 资助金额:
    $144.06万
  • 财政年份:
    2018
  • 负责人:
    Pugh Trevor J
  • 依托单位:
海外基金